首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure.
【24h】

Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure.

机译:血浆转化生长因子β1作为生化标志物,预测手术迷宫手术后房颤的持续存在。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: The Cox maze procedure was developed as a surgical treatment for atrial fibrillation. However, atrial fibrillation recurs in some patients, and atrial remodeling in the form of fibrosis can lead to perpetuation of atrial fibrillation. To identify the predictor of the persistence of atrial fibrillation after the maze procedure using cryoablation, we evaluated the preoperative plasma transforming growth factor beta1. We also examined the correlations between plasma transforming growth factor beta1 levels and the degree of atrial fibrosis. METHODS: Preoperative plasma transforming growth factor beta1 levels were measured in 86 consecutive patients (age, 54 +/- 12 years) who underwent both the open heart operation for valvular heart disease and the surgical maze procedure with cryoablation for persistent atrial fibrillation. We measured the degree of fibrosis from the tissue of the left atrium. RESULTS: At 1 year's follow-up, 10 of 86 patients had persistent atrial fibrillation. Patients with persistent atrial fibrillation had higher preoperative plasma transforming growth factor beta1 levels than the patients with sinus rhythm (0.44 +/- 0.29 vs 0.32 +/- 0.15 ng/mL, P = .03). Patients with persistent atrial fibrillation had higher mRNA expressions of collagen III and lower mRNA expressions of atrial natriuretic peptide than those with sinus rhythm, and the plasma transforming growth factor beta1 levels correlated with the degree of fibrosis in the left atrium (r = 0.497, P = .022). Multiple logistic regression analysis revealed that plasma transforming growth factor beta1 levels were independently associated with the postoperative persistence of atrial fibrillation at 1 year's follow-up. CONCLUSIONS: Preoperative plasma transforming growth factor beta1 levels could be used to predict the persistence of atrial fibrillation at 1 year's follow-up after the surgical maze procedure by using cryoablation. Preoperative plasma transforming growth factor beta1 levels were correlated with the degree of fibrosis in the left atria of patients with mitral valvular heart disease.
机译:目的:Cox迷宫手术是作为房颤的外科手术治疗开发的。但是,某些患者会发生房颤,而以纤维化形式发生的房重构会导致房颤的持续。为了确定使用冷冻消融迷宫手术后房颤持续存在的预测因素,我们评估了术前血浆转化生长因子β1。我们还检查了血浆转化生长因子beta1水平与心房纤维化程度之间的相关性。方法:对连续接受心脏瓣膜病心脏直视手术和冷冻消融持续房颤的外科迷宫手术的86例连续患者(年龄54 +/- 12岁)进行术前血浆转化生长因子β1水平的测量。我们测量了来自左心房组织的纤维化程度。结果:在1年的随访中,86例患者中有10例持续性房颤。持续性房颤患者术前血浆转化生长因子β1水平高于窦性心律患者(0.44 +/- 0.29 vs 0.32 +/- 0.15 ng / mL,P = .03)。持续性房颤患者的窦性心律较之窦性心律患者,其胶原III mRNA表达更高,而钠尿利钠肽mRNA表达更低,血浆转化生长因子β1水平与左心房纤维化程度相关(r = 0.497,P = .022)。多元logistic回归分析显示,血浆转化生长因子β1水平在1年的随访中与心房纤颤的术后持续存在独立相关。结论:术前血浆转化生长因子β1水平可用于预测冷冻迷宫手术后1年随访中的房颤持续性。术前血浆转化生长因子β1水平与二尖瓣心脏病患者左心房纤维化程度相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号